Merap Pharmaceutical

Merap Group is a leading pharmaceutical company in Vietnam, specializing in the development, manufacturing, and distribution of high-quality healthcare products. Founded in 1999, the company has established a dominant market position with well-known brands such as Xisat (deep-sea water nasal spray) and Osla (eye drops). In 2023, Alcon, a global leader in eye care, acquired a majority stake in Merap Group to expand its presence in the Vietnamese market and leverage Merap's robust distribution network. The company operates state-of-the-art manufacturing facilities in Hung Yen province that comply with WHO-GMP standards. Merap's portfolio spans several therapeutic areas, including ophthalmology, respiratory health, and infectious diseases, focusing on delivering international-standard products at affordable prices.